Research page
Ipamorelin

Specification
| Name | Ipamorelin |
|---|---|
| Catalog sizes | 10 mg |
| Adopted bacteriostatic water | 10 mg + 2.0 mL = 5 mg/mL |
Overview
Ipamorelin is a pentapeptide secretagogue. The 1998 paper described it as selective for growth-hormone release in laboratory models, with less effect on cortisol and prolactin than earlier secretagogues. The TRACE vial is 10 mg.
Mechanism under study
It acts at the growth-hormone secretagogue receptor (the ghrelin pathway), which is distinct from the GHRH receptor. It stimulates a pituitary signal; it is not growth hormone.
What published research has reported
TRACE cites the paper by Raun and colleagues (1998) as a laboratory description. It does not turn it into an amount for a person.
Composition and mass
10 mg vial. Adopted bacteriostatic water: 2 mL (5 mg/mL).
Reconstitution
| mg | mL | mg/mL | |
|---|---|---|---|
| 10 | 2.0 | 5 | In the catalog |
Storage and handling
Lyophilized material cool, dry, and protected from light. Dissolved: 2–8 °C, not frozen, 28-day horizon.
Regulatory status
Research material. Not an approved medicine or a supplement.